Tags: Chemical Compound, Chemical Substance.

Saralasin is a partial agonist of angiotensin II receptors though it is commonly mistaken as a competitive antagonist. Saralasin’s distinction as a partial agonist is based on the fact that its therapeutic effect (i.e. reduced hypertension) is only observed in patients with high plasma angiotensin II levels but in patients with low angiotensin II levels Saralasin causes hypertension.

Saralasin.png
FDA UNII code
H2AFV2HE66
IUPAC name
(2S)-2-(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid

Loading...

This page contains content from the copyrighted Wikipedia article "Saralasin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.